article thumbnail

Building Patient Trust in Digital Health Software

MedCity News

The apps also need to be designed to be inclusive of different needs including patients with disabilities, different levels of tech literacy, and diverse needs. The post Building Patient Trust in Digital Health Software appeared first on MedCity News.

Patients 268
article thumbnail

Patient Dies in Gene Therapy Trial, But FDA Permits Neurogene to Proceed With Low Dose

MedCity News

A patient death in a clinical trial usually prompts the FDA to impose a clinical hold. The post Patient Dies in Gene Therapy Trial, But FDA Permits Neurogene to Proceed With Low Dose appeared first on MedCity News.

FDA 294
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How AI Will Change the ePrescribing Experience for Patients, Providers and Pharmacies

MedCity News

There are a number of important ways AI will impact patients, providers and pharmacies in the coming year. The post How AI Will Change the ePrescribing Experience for Patients, Providers and Pharmacies appeared first on MedCity News. They break down into three key areas.

Patients 258
article thumbnail

Battling Ransomware: How Healthcare Organizations Can Strengthen Cybersecurity to Protect Patient Data

MedCity News

The post Battling Ransomware: How Healthcare Organizations Can Strengthen Cybersecurity to Protect Patient Data appeared first on MedCity News. Here are some areas where organizations should be focusing their efforts.

article thumbnail

Making the Case for Case Management for Cell and Gene Therapies

Deviations from the intended supply chain can delay timelines and affect these high value products, which can be detrimental to budgets, but more importantly can have dire effects on the patients whose lives depend on receiving these critical doses safely and on time.

article thumbnail

Driving Genetic Testing Adoption and Improved Patient Care through Health Data Intelligence

MedCity News

The post Driving Genetic Testing Adoption and Improved Patient Care through Health Data Intelligence appeared first on MedCity News.

Patients 309
article thumbnail

Novo Nordisk Launches Lower-Cost Wegovy, Following Eli Lilly Into Direct-to-Patient Sales

MedCity News

Wegovy will ship directly to eligible patients through NovoCare, an online pharmacy established by Novo Nordisk. The products price matches a recent price cut for Zepbound offered by Eli Lilly through its own direct-to-patient online platform.

Sales 230
article thumbnail

Running Decentralized Trials at Scale: Planning for Success

The potential for reaching a larger pool of recruits is possible when sponsors can bring more trial activities to the patient. There’s been a rapid shift towards decentralization in clinical trials & it’s clear why.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven decision-making.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. Clinical trial data management is increasingly challenging as studies grow in complexity. In this paper, we explore real-time data access and analysis for proactive study management.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

Learning Objectives: Dose-response curves and patient treatment: How do pharmacologic and toxicologic principles apply to the dosing of drugs in clinical development? Ben Locwin will discuss the potential effects of this draft, along with the pharmacological and toxicological considerations for optimizing doses of prescription drugs.